✦ LIBER ✦

PCN28 COST-UTILITY ANALYSIS IN A SPANISH SETTING OF ADJUVANT THERAPY WITH TRASTUZUMAB (HERCEPTIN®) IN PATIENTS WITH HER-2 POSITIVE BREAST CANCER

✍ Scribed by C Polanco; M Carulla; X Badia; A Ramirez-Arellano

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN39 COST-UTILITY ANALYSIS IN A FRENCH

✍ F Fagnani; X Colin; P Arveux; C Coudray-Omnès 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJU

✍ E Orlewska; T Pienkowski; K Drosik; M Gyldmark; R Aultman; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCN4 BUDGET IMPACT ANALYSIS OF ADJUVANT

✍ E Orlewska; R Aultman; M Krzakowski; T Pienkowski; K Drosik; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN102 COST EFFECTIVENESS ANALYSIS OF AD

✍ G Giuliani; JA Ray; A Urspruch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PCN16 COST-EFFECTIVENESS ANALYSIS OF ADJ

✍ TY Chao; SC Chen; KJ Chang; HK Chang; DR Chen; MF Hou; RK Hsieh; WT Huang; LM Ts 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCN21 SYSTEMATIC REVIEW OF COST-EFFECTIV

✍ OA Le 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB